Olympus (OTCMKTS:OCPNY) Shares Pass Above 50-Day Moving Average – Time to Sell?

Olympus Co. (OTCMKTS:OCPNY)’s stock price crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $18.00 and traded as high as $18.00. Olympus shares last traded at $18.00, with a volume of 400 shares traded.

Analysts Set New Price Targets

Separately, Jefferies Financial Group upgraded Olympus to a “buy” rating in a report on Monday, May 18th. One analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy”.

Olympus Trading Down 1.4%

The firm’s 50 day simple moving average is $18.00 and its 200-day simple moving average is $18.00. The company has a market capitalization of $23.15 billion, a PE ratio of 21.95, a P/E/G ratio of 1.07 and a beta of 0.70. The company has a quick ratio of 1.48, a current ratio of 1.99 and a debt-to-equity ratio of 0.59.

About Olympus

Olympus Corporation is a Tokyo-headquartered manufacturer specializing in medical and scientific imaging, precision optics and related equipment. The company’s medical systems business is focused on endoscopic technologies and therapeutic devices used in minimally invasive diagnosis and treatment, supplying hospitals and clinical facilities with endoscopes, visualization platforms and accessories. In addition to healthcare, Olympus serves scientific and industrial customers with microscopes, imaging systems, non-destructive testing equipment and precision measurement tools used in research, manufacturing and quality control.

In recent years the company completed a strategic refocus on healthcare and scientific solutions, divesting its consumer camera business in 2020 to concentrate resources on medical device development, services and life-science applications.